Lately, microdeletions of the 22q region, responsible for DiGeorge syndrome or velocardiofacial syndrome, have been increasingly related to neuropsychiatric disorders including schizophrenia and bipolar disorder. These manifestations seem to be related to certain genes located in the hemideleted region such as the proline dehydrogenase (PRODH) and the catechol-o-methyltransferase (COMT) genes.
Introduction
Patients with a 22q11.2 deletion syndrome, usually present developmental delay, poor growth, distinctive facial features, microcephaly, cleft palate, heart abnormalities and immunological problems. Recent studies show that some are likely to develop psychotic symptoms, depression, anxiety and bipolar disorder [1] . The loss of one copy of susceptible genes located in the 22q11del region such as the COMT gene, an intracellular postsynaptic enzyme that modulates dopamine clearance, and PRODH gene may ultimately lead to a psychiatric dysfunction [2] .
The PRODH gene encodes proline dehydrogenase or proline oxidase (POX), a mitochondrial enzyme involved in proline catabolic pathway converting proline to 
